Pharmacy

Climate change, expected to make several deadly tropical diseases more widespread, will create a business opportunity for some pharmaceutical companies, according to a Morgan Stanley research note cited by Business Insider.

The White House earlier in July scrapped a proposal to ban drug rebates, but a Senate panel wants to resurrect the ban in the final version of its drug-pricing bill, according to CNBC.

The FDA has approved Eli Lilly's treatment for severe hypoglycemia, the first emergency treatment that can be administered without an injection.

President Donald Trump met with pharmaceutical executives at the White House this week, according to The Hill.

Medicare spent $26 billion in recent years on dozens of medicines that three other wealthy nations didn't recommend for coverage because they deemed them to be of little value, according to a new study cited by STAT.

The Trump administration is working on an executive order that would lower prices on all branded drugs sold to Medicare Part B and Part D,  according to an exclusive Reuters report. 

In the last two weeks, several hospitals announced plans to implement innovative partnerships, programs or technology to improve pharmacy operations. 

New Jersey-based Celgene will pay $55 million to resolve a class-action suit that accused the drugmaker of blocking generic competition in the cancer market at the expense of patients.

A former sales representative for Sun Pharmaceuticals filed a retaliation lawsuit against the drugmaker, claiming he was fired for complaining about its marketing tactics, according to STAT news. 

Jubilant Cadista Pharmaceuticals, a drugmaker based in Maryland, is recalling one lot of its  drospirenone and ethinyl estradiol birth control tablets over concerns that they might not work properly, the company said this week.